Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Aegerion Pharmaceuticals, Inc.
Biological Products Except Diagnostic Substances MA, United States
Nasdaq: AEGR
Company Description
Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It is engaged in the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company's lead product, lomitapide, is a small molecule, oral therapy to treat severe lipid disorders for an orphan patient population. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.
Similar to: ALLENEX AB, Cardium Therapeutics, Inc., BioTime, Inc.
Featured Company
Aben Resources Ltd.
Vancouver, BC, CA
Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →
Social Monitor
You may also be interested in:
BioTime, Inc.
Alameda, CA, US
BioTime, Inc. is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of… Learn more →
Cardium Therapeutics, Inc.
San Diego, CA, US
Cardium Therapeutics, Inc. is an asset-based, health sciences and regenerative medicine company focused on acquiring and strategically… Learn more →
ALLENEX AB
Stockholm, SE
Allenex is a life science-company that develops, manufacture, market and sell products for safer transplants of organs and bone marrow… Learn more →